Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia.

MLA

Pohlen, Michele, et al. “Combination of Romiplostim and Rituximab: Effective Therapy of Severe Immune Thrombocytopenia.” European Journal of Haematology, vol. 84, no. 4, Apr. 2010, pp. 362–64. EBSCOhost, https://doi.org/10.1111/j.1600-0609.2009.01406.x.

APA

Pohlen, M., Sargin, B., Zicholl, S., Bisping, G., Müller-Tidow, C., Berdel, W. E., Mesters, R., & Koschmieder, S. (2010). Combination of romiplostim and rituximab: effective therapy of severe immune thrombocytopenia. European Journal of Haematology, 84(4), 362–364. https://doi.org/10.1111/j.1600-0609.2009.01406.x

Chicago

Pohlen, Michele, Bülent Sargin, Stefan Zicholl, Guido Bisping, Carsten Müller-Tidow, Wolfgang E. Berdel, Rolf Mesters, and Steffen Koschmieder. 2010. “Combination of Romiplostim and Rituximab: Effective Therapy of Severe Immune Thrombocytopenia.” European Journal of Haematology 84 (4): 362–64. doi:10.1111/j.1600-0609.2009.01406.x.